Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab continuation versus cessation in severe eosinophilic asthma
NL-OMON42751Phase 4Active, not recruiting
- Sponsor
- GSK
- Start
- Apr 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of mepolizumab, sponsored by GSK. Started Apr 2016; status: active, not recruiting.
02
Drugs
mepolizumab
Beyond the preview
Go deeper on NL-OMON42751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42751.